Biological action and clinical application of shark liver oil;Mechanizm działania i zastosowanie kliniczne oleju z wa̧troby rekina

Polski Merkuriusz Lekarski

Volumn 20, Issue 119, 2006, Pages 598-601

  Lewkowicz, Natalia ^a,b   Lewkowicz, Przemysław ^a,b   Kurnatowska, Anna ^a,b   Tchórzewski, Henryk ^a,b  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b POLISH MOTHER S MEMORIAL HOSPITAL RESEARCH INSTITUTE   (Poland)

Author keywords

Alkylglycerols; Cancer therapy; Immunotherapy; Shark liver oil; Squalene

Indexed keywords

CYTOTOXIC AGENT; DIACYLGLYCEROL; FISH OIL; GLYCEROL DERIVATIVE; POLYUNSATURATED FATTY ACID; SQUALENE; THROMBOCYTE ACTIVATING FACTOR;

ANGIOGENESIS; ANTIGEN PRESENTATION; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; BIOLOGICAL ACTIVITY; CANCER CHEMOTHERAPY; DRUG ACTIVITY; DRUG INHIBITION; HUMAN; IMMUNE DEFICIENCY; IMMUNE RESPONSE; INFLAMMATION; MEMBRANE TRANSPORT; REVIEW; SHARK; SIGNAL TRANSDUCTION; TUMOR CELL;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; DIGLYCERIDES; FISH OILS; HUMANS; INFLAMMATION; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PLATELET ACTIVATING FACTOR; SHARKS; SIGNAL TRANSDUCTION; SQUALENE;

EID: 33744482864     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (35)

1. Ahn Y.K., Kin J.H.: Effects of squalene on the immune response in mice (II). Cellular and non-specific immune response and antitumor activity of squalene. Arch. Pharmacol. Res., 1992, 15, 20-29.
2. Allison A.: Squalene and squalene emulsions as adjuvants. Methods Enzymol., 1999, 19, 87-93.
3. Berggen M.I., Gallegos A., Dressler L.A.: Inhibiton of the signaling enzyme phosphatodylinositol-3-kinase by antitumor ether lipid analogues. Cancer Res., 1993, 53, 4297-4302.
4. Brohult A., Brohult J., Brohult S. i wsp.: Reduced mortality in cancer patients after administration of alkoxyglycerols. Acta Obst. Gynecol. Scand., 1986, 65, 779-785.
5. Brohult A., Brohult J., Brohult S.: Regression of tumor growth after administration of alkoxyglicerols. Acta Obst. Gynecol. Scand., 1978, 57, 79-83.
6. Brohult A.: Alkoksyglycerols and their use in radiation treatment. Acta Radiol., suppl., 1963, 233, 1-99.
7. Calder P.C.: More good news about fish oil. Nutrition, 2001, 17, 158-160.
8. Diomede L., Piovani B., Re F.: The induction of apoptosis is a common feature of the cytotoxic action of ether-linked glycerophospholipids in human leucemic cells. Int. J. Cancer., 1994, 57, 645-649.
9. Erdlenbruch B., Jendrossek V., Eibl H. i wsp.: Transient and centrallable opening of the blood-brain barrier to cytostatic and antibiotic agents by alkylglycerols in rats. Exp. Brain Res., 2000, 135, 417-422.
10. Erdlenbruch B., Schinkhof C., Kugler W. i wsp.: Intracarotid administration of short-chain alkylglycerols for increased delivery of methotrexate to the rat brain. Br. J. Pharmacol., 2003, 139, 685-694.
11. Hichami A., Duroudier V., Leblais V. i wsp.: Modulation of platelet-activating factor production by incorporation of naturally occurring 1-O-alkylglycerols in phospholipids of human leukemic monocyte-like THP-1 cells. Eur. J. Biochem., 1997, 250, 242-248.
12. Hirai O., Hayashi K., Konishi Y. i wsp.: Influence of squalene on the antitumour action of cell wall skeleton from nocardia rubra. Oyo Yakuri Farmacometrics Sci., 1986, 31, 649-656.
13. Ikekawa T., Umeji M., Manabe T. i wsp.: Studies on antitumor activity of squalene and it's related compounds. Yakuguku Zasshi, 1986, 106, 578-582.
14. Kang SJ.: Similarities in the lipid class of oils from Atlantic and Pacific dogfish livers. JAOCS, 1998, 75, 1667-1675.
15. Krotkiewski M., Przybyszewska M., Janik P.: Cytostatic and cytotoxic effects of alkylglycerols (Ecomer). Med. Sci. Monit., 2003, 9, 131-135.
16. Kuroda Y., Nacionales D.C., Akaogi J.: Autoimmunity induced by adjuvant hydrocarbon oil components of vaccine. Biomed. Pharmacother., 2004, 58, 325-337.
17. Lanza-Jacoby S., Flynn J.T., Miller S.: Parenteral supplementation with a fish-oil emulsion prolongs survival and improves rat lymphocyte function during sepsis. Nutrition, 2001, 17, 112-116.
18. Lewkowicz P., Banasik M., Glowacka E. i wsp.: Modyfikuja̧cy wpływ dużych dawek preparatu oleju z wa̧troby rekina na polaryzacjȩ limfocytów T oraz funkcjȩ neutrofili krwi. Pol. Merk. Lek., 2005, 108, 686-692.
19. Lewkowicz P., Lewkowicz N., Tchórzewski H.: Rola alkilogliceroli, skwalenu i wielonienasyconych kwasów omega 3 w zwalczaniu infekcji bakteryjnych - modyfikacja naturalnych (wrodzonych) mechanizmów odporności. Problemy Ter. Mon., 2002, 13, 163-169.
20. Miettinen T.A., Vanhanen H.: Serum concentration and metabolism of cholesterol during rapeseed oil and squalene feeding. Am. J. Clin. Nutr., 1994, 59, 356-363.
21. Ngwenya B.Z., Foster D.M.: Enhancement of antibody production by lysophosphatidylocholine and alkylglycerol. Proc. Soc. Exp. Biol. Med., 1990, 196, 69-75.
22. Pedrono F., Cheminade C., Legrand A.B.: Natural 1-O-alkyllglycerols reduce platelet-activating factor-induced release of [3H]-serotonine in rabbit platelets. Prostaglandins Leukot. Essent. Fatty Acids, 2004, 71, 19-23.
23. Pedrono F., Khan N.A., Legrand A.B.: Regulation of calcium signalling by 1-O-alkyllglycerols in human Jurkat T lymphocytes. Life Sci., 2004, 16, 2793-2801.
24. Pugliese P.T., Jordan K., Cederberg H. i wsp.: Some biological action of alkylglycerols from shark liver oil. J. Altern. Complement. Medicine, 1998, 4, 87-99.
25. Robinsosn M., Burdone R., Warne T.R.: Inhibition of phorbol ester-stimulated arachidonic acid release by alkylglycerols. Biochim. Biophys. Acta., 1995, 1254, 361-367.
26. Sommer E., Demkow U., Skurzak H.: Inhibitory effect of Greenland shark liver oil combined with squalen and arctic birch ashes on angiogenesis and sarcoma growth in Balb/c mice. Pol. J. Vet. Sci., 2003, 6, 54-56.
27. Skopińska-Rozewska E., Krotkiewski M., Sommer E. i wsp.: Inhibitory effect of shark liver oil on cutaneous angiogenesis induced in Balb/c mice by syngeneic sarcoma L-1, human urinary bladder and human kidney tumor cells. Oncol. Rep., 1999, 6, 1341-1344.
28. Stranberg T.E., Tilvis R.S., Mietinen T.A.: Metabolic variables of cholesterol during sqalene feeding in humans: comparison with cholestyramine treatment. J. Lipid Res., 1990, 31, 1637-1643.
29. Triggiany M., Schleimer R.P., Warner J.A. i wsp.: Differential synthesis of 1-acyl-2-acetyl-sn-glycero-3-phosphocholine and platelet-activating factor by human inflammatory cells. J. Immunol., 1991, 147, 660-666.
30. Van Sickle W.A., Angelastro M.R., Wilson P. i wsp.: Inhibition of cholesterol synthesis by cyklopropylamine derivatives of sqalene in human hepatoblastoma cells in culture. Lipids, 1992, 27, 157-163.
31. Wagner B.A., Buettner G.R., Burns P.C.: Membrane peroxidative damage enhancement by the ether lipid class of anti-neoplastic agents. Cancer Res., 1992, 52, 6045-6057.
32. Wang H., Rajagopal S., Reynolds S.: Differentiation-promoting effect of 1-O (2 methoxy) hexadecyl glycerol in human colon cancer cell. J. Cell Physiol., 1999, 178, 173-178.
33. Yakoni E., Melcer M.S., Rapp H.J.: Tumour regression after intralesional injection of emulsified trehalose - 6,6,- dimykolate: efficacy increased with oil concentration. Int. J. Cancer., 1997, 19, 818-825.
34. Yamaguchi T., Nakagawa M., Hidaka K. i wsp.: Potentiation by squalene of antitumor activity of 3-[(4-amino-2-methyl-5pyrimidynyl) methyl]-1-(2- chloroethyl)-nitrotezeula in murine tumour system. J. Cancer Res., 1985, 76, 1021-1030.
35. Zhang Z., Yeung W.K., Huang Y. i wsp.: Effect of squalene and shark liver oil on serum cholesterol level in hamsters. Int. J. Food. Sci. Nutr., 2002, 53, 411-418.